500788-93-2

Basic information

• Product Name: (R)-BOC-3 4-DIMETHOXY-BETA-PHE-OH
• Synonyms: (r)-boc-3,4-dimethoxy-β-phe-oh;Boc-D-b-Phe(3,4-dimethoxy)-OH;(R)-3-(Boc-amino)-3-(3,4-methoxyphenyl)propionic acid, Boc-3,4-dimethoxy-L-β-phenylalanine;Boc-3,4-DiMethoxy-D-b-phenylalanine;(R)-3-((TERT-BUTOXYCARBONYL)AMINO)-3-(3,4-DIMETHOXYPHENYL)PROPANOIC ACID;(Tert-Butoxy)Carbonyl (R)-3-Amino-3-(3,4-dimethoxy-phenyl)propionic acid
• CAS NO: 500788-93-2
• Molecular Formula: C16H23NO6
• Molecular Weight: 325.359
• Mol File: 500788-93-2.mol

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: (R)-BOC-3 4-DIMETHOXY-BETA-PHE-OH(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-BOC-3 4-DIMETHOXY-BETA-PHE-OH(500788-93-2)
• EPA Substance Registry System: (R)-BOC-3 4-DIMETHOXY-BETA-PHE-OH(500788-93-2)

Safety Data

• WGK Germany: 3
• Hazardous Substances Data: 500788-93-2(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
(R)-BOC-3 4-DIMETHOXY-BETA-PHE-OH is used as a building block for the preparation of various peptide-based pharmaceuticals and bioactive molecules. Its chiral and aromatic properties, along with the protective BOC group, make it a crucial component in the synthesis of diverse peptide-based compounds with potential pharmaceutical and biological applications.
Used in Peptide Synthesis:
(R)-BOC-3 4-DIMETHOXY-BETA-PHE-OH is used as a key component in peptide synthesis, where the BOC group provides protection for the amine functional group, allowing for selective deprotonation and subsequent coupling reactions. This enables the formation of complex peptide structures with desired biological activities.

Upstream product

• 120-14-9 3,4-dimethoxy-benzaldehyde 
• 5763-61-1 3,4-dimethoxybenzylamine 
• 24424-99-5 di-tert-butyl dicarbonate 
• 34840-85-2 3-amino-3-(3,4-dimethoxyphenyl)propanoic acid 

Downstream Products

• 1078052-82-0 C₂₃H₃₅NO₇ 
• 1078052-81-9 C₂₃H₃₅NO₇ 
• 1078052-83-1 C₁₇H₂₃NO₄ 
• 1078052-84-2 6-(3,4-dimethoxyphenyl)-4-isobutoxy-5,6-dihydropyridin-2(1H)-one 
• 1078052-85-3 C₁₇H₂₅NO₄ 
• 1078052-79-5 C₁₇H₂₇NO₃ 
• 1078052-96-6 C₁₇H₂₁NO₄ 
• 1078052-97-7 C₁₃H₁₅NO₄ 

Relevant articles and documents

GLUCOSE METABOLISM MODULATING COMPOUNDS

The present invention provides, inter alia, dihydropyridone compounds and compositions, including analogs of a vesicular monoamine transporter type 2 (VMAT2) antagonist. The present invention also provides methods of using such compounds/analogs for modulating glucose levels, and/or preventing, treating, or ameliorating the effects of diabetes and hyperglycemia.

HYPOGLYCEMIC DIHYDROPYRIDONES

The present invention provides, inter alia, a compound of formula I: wherein the substituent designations are indicated in the Specification. The present invention also provides pharmaceutical compositions comprising a compound of formula I, and methods o

New entry to the asymmetric synthesis of (-)-lasubine I and (+)-subcosine I

A new synthetic entry to (-)-lasubine I and (+)-subcosine I has been established by employing the (S)-allylalkoxy benzylamine as a chiral synthon. The synthesis involves the formation of an α,β-unsaturated lactone by RCM reaction followed by an intramolec

Novel hypoglycemic dihydropyridones serendipitously discovered from O- versus C-alkylation in the synthesis of VMAT2 antagonists

Vesicular monoamine transporter type 2 (VMAT2) is a newly emerging target for both diagnostic and therapeutic applications in diabetes mellitus. In pursuit of novel VMAT2 antagonists, we identified a potent hypoglycemic agent with a novel dihydropyridone